Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Other Working Capital Changes (2020 - 2026)

Nuvalent's (NUVL) quarterly Other Working Capital Changes came in at $3.0 million in Q1 2026, down 66.94% YoY from $9.2 million in Q1 2025, and down 54.32% on a QoQ basis from $6.6 million in Q4 2025.

Analysis

Nuvalent (NUVL) Other Working Capital Changes (2020 - 2026) Analysis & Trends

Nuvalent (NUVL) has 7 years of Other Working Capital Changes data on file, last reported at $3.0 million in Q1 2026.

  • Quarterly Other Working Capital Changes fell 66.94% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $195000.0 (down 98.57% YoY) and the FY2025 annual result came in at $6.3 million, down 16.14% from the prior year.
  • Other Working Capital Changes retreated to $3.0 million in Q1 2026, from $6.6 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $9.2 million in Q1 2025 to a low of -$11.3 million in Q3 2025.
  • A 5-year average of $1.1 million and a median of $1.0 million in 2022 frame the typical range for Other Working Capital Changes.
  • Annual changes were most pronounced in 2022 — Other Working Capital Changes plunged 3000.0% — and 2024, when it surged 3988.24%.
  • Tracing NUVL's Other Working Capital Changes over 5 years: stood at $374000.0 in 2022, then slumped by 81.82% to $68000.0 in 2023, then surged by 3988.24% to $2.8 million in 2024, then surged by 139.06% to $6.6 million in 2025, then tumbled by 54.32% to $3.0 million in 2026.
  • The last three Other Working Capital Changes figures came in at $3.0 million (Q1 2026), $6.6 million (Q4 2025), and -$11.3 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Nuvalent 9.75 Bn 9.75 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3,000.00
Mar 31, 2026 3,000.00
Dec 31, 2025 6.65 Mn
Dec 31, 2025 6.65 Mn
Sep 30, 2025 -170,000.00
Sep 30, 2025 -170,000.00
Jun 30, 2025 684,000.00
Jun 30, 2025 684,000.00
Mar 31, 2025 -818,000.00
Mar 31, 2025 -818,000.00
Dec 31, 2024 2.78 Mn
Dec 31, 2024 2.78 Mn
Sep 30, 2024 3.10 Mn
Sep 30, 2024 3.10 Mn
Jun 30, 2024 607,000.00
Jun 30, 2024 607,000.00
Mar 31, 2024 1.07 Mn
Mar 31, 2024 1.07 Mn
Dec 31, 2023 68,000.00
Dec 31, 2023 68,000.00